A novel indocyanine green-based fluorescent marker for guiding surgical tumor resection

Jiawei Ge; Justin D. Opfermann; Hamed Saeidi; Katherine A. Huenerberg; Christopher D. Badger; Jaepyeong Cha; Martin J. Schnermann; Arjun S. Joshi; Axel Krieger

doi:10.1142/s1793545821500139

[1] C. Yoo, S. H. Shin, K. Kim et al., "Clinical outcomes of conversion surgery after neoadjuvant chemotherapy in patients with borderline resectable and locally advanced unresectable pancreatic cancer: A single-center, retrospective analysis," Cancers 11(3), 278 (2019). doi: 10.3390/cancers11030278.

[2] W. L. Shaib, A. Ip, K. Cardona et al., "Contemporary management of borderline resectable and locally advanced unresectable pancreatic cancer," Oncologist 21(2), 178–187 (2016). doi: 10.1634/theoncologist.2015-0316.

[3] M. Basso, V. Dadduzio, F. Ardito et al., "Conversion chemotherapy for technically unresectable colorectal liver metastases," Medicine (Baltimore) 95(20), e3722 (2016). doi: 10.1097/ MD.0000000000003722.

[4] M. Abufaraj, K. Gust, M. Moschini et al., "Management of muscle invasive, locally advanced and metastatic urothelial carcinoma of the bladder: a literature review with emphasis on the role of surgery," Transl. Androl. Urol. 5(5), 735–744 (2016). doi: 10.21037/tau.2016.08.23.

[5] J. Sun, D. A. Kirichenko, J. S. Zager, Z. Eroglu, "The emergence of neoadjuvant therapy in advanced melanoma," Melanoma Manag. 6(3), MMT27 (2019). doi: 10.2217/mmt-2019-0007.

[6] D. Uprety, S. J. Mandrekar, D. Wigle, A. C. Roden, A. A. Adjei, "Neoadjuvant immunotherapy for NSCLC: current concepts and future approaches," J. Thorac. Oncol. 15(8), 1281–1297 (2020). doi: 10.1016/j.jtho.2020.05.020.

[7] N. Sadeghi, N.-W. Li, M. R. Taheri, S. Easley, R. S. Siegel, "Neoadjuvant chemotherapy and transoral surgery as a definitive treatment for oropharyngeal cancer: A feasible novel approach," Head Neck 38 (12), 1837–1846 (2016). doi: 10.1002/hed.24526.

[8] N. Sadeghi, M. A. Mascarella, S. Khalife et al., "Neoadjuvant chemotherapy followed by surgery for HPV-associated locoregionally advanced oropharynx cancer," Head Neck 42(8), 2145–2154 (2020). doi: 10.1002/hed.26147.

[9] N. Sadeghi, S. Khalife, M. A. Mascarella et al., "Pathologic response to neoadjuvant chemotherapy in HPV-associated oropharynx cancer," Head Neck 42(3), 417–425 (2020). doi: 10.1002/hed.26022.

[10] A. Patil, R. Anand, P. Mahajan, "Comparative study of acrylic color and India ink for their use as a surgical margin inks in oral squamous cell carcinoma," World J. Dent. 6(1), 26–30 (2015). doi: 10.5005/jp-journals-10015-1308.

[11] M. Yang, D. Pepe, C. M. Schlachta, N. A. Alkhamesi, "Endoscopic tattoo: the importance and need for standardised guidelines and protocol," J. R. Soc. Med. 110(7), 287–291 (2017). doi: 10.1177/ 0141076817712244.

[12] B. K. Kim, M. H. Song, H. J. Yang, D. S. Kim, N. K. Lee, Y. S. Jeon, "Use of cystoscopic tattooing in laparoscopic partial cystectomy," Korean J. Urol. 53(6), 401–404 (2012). doi: 10.4111/kju.2012. 53.6.401.

[13] M. R. Hwang, D. K. Sohn, J. W. Park et al., "Smalldose India ink tattooing for preoperative localization of colorectal tumor," J. Laparoendosc. Adv. Surg. Tech. A, 20(9), 731–734 (2010). doi: 10.1089/ lap.2010.0284.

[14] R. Haque, R. Contreras, M. P. McNicoll, E. C. Eckberg, D. B. Petitti, "Surgical margins and survival after head and neck cancer surgery," BMC Ear Nose Throat Disord. 6, 2 (2006). doi: 10.1186/1472- 6815-6-2.

[15] H. W. Herr, "Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy," Urology 61(1), 105–108 (2003). doi: 10.1016/S0090-4295(02) 02116-7.

[16] W. S. Tummers, J. V. Groen, B. G. Sibinga Mulder et al., "Impact of resection margin status on recurrence and survival in pancreatic cancer surgery," Br. J. Surg. 106(8), 1055–1065 (2019). doi: 10.1002/ bjs.11115.

[17] U. Boggi, N. Napoli, F. Costa et al., "Roboticassisted pancreatic resections," World J. Surg. 40(10), 2497–2506 (2016). doi: 10.1007/s00268-016- 3565-3.

[18] G. Cheung, A. Sahai, M. Billia, P. Dasgupta, M. S. Khan, "Recent advances in the diagnosis and treatment of bladder cancer," BMC Med. 11(1), 13 (2013). doi: 10.1186/1741-7015-11-13.

[19] R. M. Jimenez Rodríguez, J. M. Díaz Pavón, F. de La Portilla de Juan, E. Prendes Sillero, J. M. Hisnard Cadet Dussort, J. Padillo, "Prospective randomised study: robotic-assisted versus conventional laparoscopic surgery in colorectal cancer resection," Cir. Esp. Engl. Ed. 89(7), 432–438 (2011). doi: 10.1016/j.cireng.2011.01.001.

[20] G. S. Weinstein, B. W. O'Malley, J. S. Magnuson et al., "Transoral robotic surgery: a multicenter study to assess feasibility, safety, and surgical margins," Laryngoscope 122(8), 1701–1707 (2012). doi: 10.1002/lary.23294.

[21] H. Saeidi, J. Ge, M. Kam et al., "Supervised autonomous electrosurgery via biocompatible near-infrared tissue tracking techniques," IEEE Trans. Med. Robot Bionics. 1(4), 228–236 (2019). doi: 10.1109/TMRB.2019.2949870.

[22] J. Ge, H. Saeidi, J. D. Opfermann, A. S. Joshi, A. Krieger, Landmark-guided deformable image registration for supervised autonomous robotic tumor resection, Medical Image Computing and Computer Assisted Intervention – MICCAI 2019, D. Shen, T. Liu, T. M. Peters et al., Eds., pp. 320– 328, Springer International Publishing (2019).

[23] T. Nagaya, Y. A. Nakamura, P. L. Choyke, H. Kobayashi, "Fluorescence-guided surgery," Front. Oncol. 7, 314 (2017). doi: 10.3389/fonc.2017.00314.

[24] ClinicalTrials.gov (NCT02129933, NCT01972373, NCT02583568, NCT03134846, NCT03405142). Accessed June 14, 2020. https://clinicaltrials.gov/.

[25] T. A. Dalsaso, V. J. Lowe, F. R. Dunphy, D. S. Martin, J. H. Boyd, B. C. Stack, "FDG-PET and CT in evaluation of chemotherapy in advanced head and neck cancer," Clin. Positron Imaging O? J. Inst. Clin. PET 3(1), 1–5 (2000). doi: 10.1016/ s1095-0397(99)00074-6.

[26] R. S. Decker, A. Shademan, J. D. Opfermann, S. Leonard, P. C. Kim, A. Krieger, "Biocompatible near-infrared three-dimensional tracking system," IEEE Trans. Biomed. Eng. 64(3), 549–556 (2017).

[27] A. Shademan, R. S. Decker, J. D. Opfermann, S. Leonard, A. Krieger, P. C. W. Kim, "Supervised autonomous robotic soft tissue surgery," Sci. Transl. Med. 8(337), 337ra64 (2016). doi: 10.1126/ scitranslmed.aad9398.

[28] S. N. Ayy?ld?z, A. Ayy?ld?z, "Cyanoacrylic tissue glues: Biochemical properties and their usage in urology," Turk. J. Urol. 43(1), 14–24 (2017). doi: 10.5152/tud.2017.09465.

[29] A. F. Nahhas, C. A. Scarbrough, S. Trotter, "A review of the global guidelines on surgical margins for nonmelanoma skin cancers," J. Clin. Aesthetic Dermatol. 10(4), 37–46 (2017).

[30] S. G. Brouwer de Koning, M.-J. T. F. D. Vrancken Peeters, K. Jó?wiak, P. A. Bhairosing, T. J. M. Ruers, "Tumor resection margin definitions in breast-conserving surgery: systematic review and meta-analysis of the current literature," Clin. Breast Cancer 18(4), e595–e600 (2018). doi: 10.1016/j. clbc.2018.04.004.

[31] G. Vallancien, H. Abou el fettouh, X. Cathelineau, H. Baumert, G. Fromont, B. Guillonneau, "Cystectomy with prostate sparing for bladder cancer in 100 patients: 10-year experience," J. Urol. 168(6), 2413–2417 (2002). doi: 10.1016/S0022-5347 (05)64157-2.

[32] M. S. Ahmed, B. Indira, Detection of exudates from RGB fundus images using 3 control method, 2017 Int. Conf. Wirel Commun. Signal Process Netw. WiSPNET. Published online 2017. doi: 10.1109/ wispnet.2017.8299864.

[33] A. Danti, Suresha, "Segmentation and classification of raw arecanuts based on three sigma control limits," Proc. Technol. 4, 215–219 (2012). doi: 10.1016/j.protcy.2012.05.032.

[34] S. Yoneya, T. Saito, Y. Komatsu, I. Koyama, K. Takahashi, J. Duvoll-Young, "Binding properties of indocyanine green in human blood," Invest. Ophthalmol. Vis. Sci. 39(7), 1286–1290 (1998).

[35] J. T. Alander, I. Kaartinen, A. Laakso et al., "A review of indocyanine green fluorescent imaging in surgery," Int. J. Biomed. Imaging 2012, 940585 (2012). doi:https://doi.org/10.1155/2012/940585.

[36] P. Jirkof, A. Tourvieille, P. Cinelli, M. Arras, "Buprenorphine for pain relief in mice: Repeated injections vs sustained-release depot formulation," Lab Anim. 49(3), 177–187 (2015). doi: 10.1177/ 0023677214562849.